Literature DB >> 30418444

Polymeric micro- and nanoparticles for immune modulation.

Elana Ben-Akiva1, Savannah Est Witte, Randall A Meyer, Kelly R Rhodes, Jordan J Green.   

Abstract

New advances in biomaterial-based approaches to modulate the immune system are being applied to treat cancer, infectious diseases, and autoimmunity. Particulate systems are especially well-suited to deliver immunomodulatory factors to immune cells since their small size allows them to engage cell surface receptors or deliver cargo intracellularly after internalization. Biodegradable polymeric particles are a particularly versatile platform for the delivery of signals to the immune system because they can be easily surface-modified to target specific receptors and engineered to release encapsulated cargo in a precise, sustained manner. Micro- and nanoscale systems have been used to deliver a variety of therapeutic agents including monoclonal antibodies, peptides, and small molecule drugs that function to activate the immune system against cancer or infectious disease, or suppress the immune system to combat autoimmune diseases and transplant rejection. This review provides an overview of recent advances in the development of polymeric micro- and nanoparticulate systems for the presentation and delivery of immunomodulatory agents targeted to a variety of immune cell types including APCs, T cells, B cells, and NK cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30418444      PMCID: PMC6664797          DOI: 10.1039/c8bm01285g

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  139 in total

1.  Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.

Authors:  Mathias Oelke; Marcela V Maus; Dominic Didiano; Carl H June; Andreas Mackensen; Jonathan P Schneck
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

Review 2.  The regulatory T cell family: distinct subsets and their interrelations.

Authors:  Helmut Jonuleit; Edgar Schmitt
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 3.  B-cell activation.

Authors:  S V Desiderio
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

4.  Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

Authors:  Frank DeStefano; Eric S Weintraub; Robert T Chen
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.

Authors:  B Chackerian; D R Lowy; J T Schiller
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

6.  Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.

Authors:  Wan-Uk Kim; Woo-Kyoung Lee; Jae-Woong Ryoo; Seung-Hoon Kim; Jin Kim; Jeehee Youn; So-Youn Min; Eui-Young Bae; Sue-Yun Hwang; Sung-Hwan Park; Chul-Soo Cho; Jong-Sang Park; Ho-Youn Kim
Journal:  Arthritis Rheum       Date:  2002-04

Review 7.  Challenges facing adjuvants for cancer immunotherapy.

Authors:  Circe Mesa; Luis E Fernández
Journal:  Immunol Cell Biol       Date:  2004-12       Impact factor: 5.126

8.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.

Authors:  Laurence D Rhines; Prakash Sampath; Francesco DiMeco; H Christopher Lawson; Betty M Tyler; Justin Hanes; Alessandro Olivi; Henry Brem
Journal:  Neurosurgery       Date:  2003-04       Impact factor: 4.654

10.  Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time.

Authors:  Anna Moore; Jan Grimm; Bingye Han; Pere Santamaria
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

View more
  19 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 2.  Nanoparticles for generating antigen-specific T cells for immunotherapy.

Authors:  Savannah E Est-Witte; Natalie K Livingston; Mary O Omotoso; Jordan J Green; Jonathan P Schneck
Journal:  Semin Immunol       Date:  2021-12-23       Impact factor: 11.130

Review 3.  Local delivery strategies to restore immune homeostasis in the context of inflammation.

Authors:  Elizabeth R Bentley; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-09-13       Impact factor: 15.470

4.  Biomaterial-enabled induction of pancreatic-specific regulatory T cells through distinct signal transduction pathways.

Authors:  Sean T Carey; Joshua M Gammon; Christopher M Jewell
Journal:  Drug Deliv Transl Res       Date:  2021-10-05       Impact factor: 4.617

5.  Induction of a higher-ordered architecture in glatiramer acetate improves its biological efficiency in an animal model of multiple sclerosis.

Authors:  Ziyuan Song; Yee Ming Khaw; Lazaro A Pacheco; Kuan-Ying Tseng; Zhengzhong Tan; Kaimin Cai; Ettigounder Ponnusamy; Jianjun Cheng; Makoto Inoue
Journal:  Biomater Sci       Date:  2020-09-30       Impact factor: 6.843

Review 6.  Novel approaches for vaccine development.

Authors:  Makda S Gebre; Luis A Brito; Lisa H Tostanoski; Darin K Edwards; Andrea Carfi; Dan H Barouch
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

7.  Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals.

Authors:  Qi Liu; Xiang Wang; Xiangsheng Liu; Yu-Pei Liao; Chong Hyun Chang; Kuo-Ching Mei; Jinhong Jiang; Shannon Tseng; Grant Gochman; Marissa Huang; Zoe Thatcher; Jiulong Li; Sean D Allen; Luke Lucido; Tian Xia; Andre E Nel
Journal:  ACS Nano       Date:  2020-12-22       Impact factor: 15.881

Review 8.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

Review 9.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

10.  Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction.

Authors:  Kelly R Rhodes; Randall A Meyer; Justin Wang; Stephany Y Tzeng; Jordan J Green
Journal:  Acta Biomater       Date:  2020-06-06       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.